“A strong, vibrant and high-quality research and innovation ecosystem is vital for driving future economic and social wellbeing …”
NSW Government’s Turning Ideas into Jobs Action Plan, January 2021





The Central Coast Hunter benefits from effective collaborative partnerships that result in commercial outcomes. Driven, in part, by the size of the region which is large enough to support the innovation environment but not too large that networks, firms and institutions are disconnected, collaboration is a common approach to complex problem solving.

88% of CCH’s MTP companies suggest they actively collaborate with other organisations to add value to their products and services. Importantly, 85% found their collaboration partner/s within the region. The ability to take advantage of local capability to meet business goals is key to the long-term success of the Central Coast Hunter ecosystem.

In terms of research, 77% of companies have created a partnership with the University of Newcastle and/or HMRI. This demonstrates the effectiveness of centrally located University campuses that enable it to play a proactive role in research, innovation and commercialisation.

The University of Newcastle and Health Services provide the requisite research and clinical validation capability required to enable the region’s MTP companies to deliver relevant products and services.

The importance of the University investing in the Gosford Hospital’s new medical facility and the Central Coast Clinical School & Research Institute is key to ensuring that the impact of research and clinical expertise is precinct-wide.


MTP Sector Capability: companies that produce and/or manufacturer biotech and medical technology

Enablers: organisations that facilitate or enable translation from invention to clinical innovation such as research organisations and health systems

Supporting Organisations: that offer professional support and increase the sector capability such as governments, incubators, clinical research organisations and consultants

When all organisations are in close proximity and collaborate, such as in the CCH precinct, rapid acceleration of innovation, entrepreneurship and innovation is enabled.


In June 2020, Regional Development Australia (RDA) Hunter and the Hunter office of the Australian Industry (Ai) Group established MedTeCCH to co-ordinate and support the Hunter’s burgeoning MTP sector.

The MedTeCCH industry network brings together Central Coast Hunter-based MedTech and Pharma companies, national industry associations, sector specialists and education and research organisations. It was formed to strengthen the Central Coast Hunter’s diverse cluster of medtech companies through collaboration.

MedTeCCH identifies medtech as the application of knowledge and skills to develop devices, medicines, procedures, and systems to solve human and animal health problems. It is taking a whole of supply chain approach to growing the sector by collaborating to solve patient-centric health needs.

MedTeCCH is:

  • The local voice and champion for the Central Coast Hunter MedTech sector
  • Leading the development of a sustainable, commercially successful MedTech ecosystem to create and capitalise on research and innovation opportunities
  • Building direct links to end-users and investors, including local and global health systems, with support for infrastructure, skills and research translation

MedTeCCH Membership/Affiliation

MedTeCCH is supported by MTPConnect, AMGC, NSW Health Pathology, Ampcontrol, Global Edge MedTech Consulting, Jurox, Whiteley Corporation, University of Newcastle, Hunter Medical Research Institute (HMRI), JHH-IP, The Ideas Hub (CCLHD), RDA Central Coast, Genesis Research Services, Paratus Clinical, Logikal Health, NSW Smart Sensing Network, Bosch Manufacturing Australia and Emeritus Prof Roy Green. It now includes 50 companies and organisations across industry, research, government and education plus affiliates & supporters.